Cargando…
Effects of statins on mitochondrial pathways
Statins are a family of drugs that are used for treating hyperlipidaemia with a recognized capacity to prevent cardiovascular disease events. They inhibit β‐hydroxy β‐methylglutaryl‐coenzyme A reductase, i.e. the rate‐limiting enzyme in mevalonate pathway, reduce endogenous cholesterol synthesis, an...
Autores principales: | Mollazadeh, Hamid, Tavana, Erfan, Fanni, Giovanni, Bo, Simona, Banach, Maciej, Pirro, Matteo, von Haehling, Stephan, Jamialahmadi, Tannaz, Sahebkar, Amirhossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061391/ https://www.ncbi.nlm.nih.gov/pubmed/33511728 http://dx.doi.org/10.1002/jcsm.12654 |
Ejemplares similares
-
Statins and the COVID-19 main protease: in silico evidence on direct interaction
por: Reiner, Željko, et al.
Publicado: (2020) -
Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system
por: Sahebkar, Amirhossein, et al.
Publicado: (2020) -
Statins and C-reactive protein: in silico evidence on direct interaction
por: Shakour, Neda, et al.
Publicado: (2020) -
Curcumin: An effective adjunct in patients with statin‐associated muscle symptoms?
por: Sahebkar, Amirhossein, et al.
Publicado: (2016) -
Targeting AMPK by Statins: A Potential Therapeutic Approach
por: Dehnavi, Sajad, et al.
Publicado: (2021)